Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM948AP)

Drug Name

MAb114 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Ebola virus infection	1D60.0	Phase 2/3	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Ebola virus Envelope glycoprotein (EV GP)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Ansuvimab	DMUMOEV	Ebola virus infection	1D60.0	Approved	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Ebola virus Envelope glycoprotein (EV GP)	TT2F0AU	VGP_EBOZM	Not Available	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT03719586) Investigational Therapeutics for the Treatment of People With Ebola Virus Disease. U.S. National Institutes of Health.
2	Ansuvimab: First Approval. Drugs. 2021 Apr;81(5):595-598.
3	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020